Dovato 50 mg/300 mg film-coated tablets (dolutegravir sodium, lamivudine) clinical trials

A study looking at using two drugs as dual anti-HIV therapy in people who have previously had brain injury caused by HIV

This study looks at a two-drug treatment (Dovato) for HIV in people who've had past HIV-related brain issues. It aims to see if this simpler treatment is safe and works well even after previous brain involvement.